Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D9MW
|
||||
Former ID |
DNC008451
|
||||
Drug Name |
4-propyl-N-(quinolin-3-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529389] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H18N2O
|
||||
Canonical SMILES |
CCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2
|
||||
InChI |
1S/C19H18N2O/c1-2-5-14-8-10-15(11-9-14)19(22)21-17-12-16-6-3-4-7-18(16)20-13-17/h3-4,6-13H,2,5H2,1H3,(H,21,22)
|
||||
InChIKey |
ACMQNRGXOSFSMZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.